Tacrolimus Dose Requirements and CYP3A5 Genotype and the Development of Calcineurin Inhibitor-Associated Nephrotoxicity in Renal Allograft Recipients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tacrolimus Dose Requirements and CYP3A5 Genotype and the Development of Calcineurin Inhibitor-Associated Nephrotoxicity in Renal Allograft Recipients

Published:2010-08 Issue:4 Volume:32 Page:394-404
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Kuypers Dirk R J,Naesens Maarten,de Jonge Hylke,Lerut Evelyne,Verbeke Kristin,Vanrenterghem Yves

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference37 articles.

1. The natural history of chronic allograft nephropathy.;Nankivell;N Engl J Med,2003

2. Primer: histopathology of calcineurin-inhibitor toxicity in renal allografts.;Liptak;Nat Clin Pract Nephrol,2006

3. Molecular comparison of calcineurin inhibitor-induced fibrogenic responses in protocol renal transplant biopsies.;Roos-van Groningen;J Am Soc Nephrol,2006

4. Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology.;Nankivell;Transplantation,2004

5. Histopathologic findings from 2-year protocol biopsies from a US multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group.;Solez;Transplantation,1998

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic drug monitoring of tacrolimus after kidney transplantation: trough concentration or area under curve‐based monitoring?;British Journal of Clinical Pharmacology;2024-06-06

2. Kidney transplantation: the recipient;Living Donor Organ Transplantation;2024

3. Tacrolimus—why pharmacokinetics matter in the clinic;Frontiers in Transplantation;2023-08-21

4. Physiologically based pharmacokinetic model combined with reverse dose method to study the nephrotoxic tolerance dose of tacrolimus;Archives of Toxicology;2023-08-12

5. Multicenter Prospective Trial Evaluating the Utility of CYP3A5 Genotype in Determining Optimal Initial Dosage of Tacrolimus in Chinese Renal Transplant Recipients;2023-03-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3